ARS Pharma (SPRY) Cuts Spending As It Chases Neffy Market Share
Neffy’s total US market share rose to 5% in Q2 2026, up from 2.5% a year earlier, and 8% in the targeted call universe versus roughly 1% where ARS’s field sales team isn’t active.
Aug 21, 2026 ·
Yahoo Finance



















